The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
FDA agrees to Actinogen six-month Phase 2b Alzheimer's Disease trial - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ Actinogen Medical Limited (ASX: ACW) is pleased to announce that the first patient has been randomized and treated in the XanaCIDD Phase 2.